{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-159143","form_type":"8-K","ticker":"SLDB","cik":"0001707502","company_name":"Solid Biosciences Inc.","filed_at":"2024-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.677849+00:00","generated_at":"2026-06-01T05:05:23.086542+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Solid Biosciences directors Koppel and Shah resign; shareholders approve doubling authorized shares to 120M","bullets":["Adam Koppel and Rajeev Shah resigned from the Board effective June 11, 2024; no disagreement cited.","Shareholders approved increase of authorized common stock from 60M to 120M shares.","Equity incentive plan amended to add 2M shares; total available for issuance increased accordingly.","Four Class III directors elected: Martin Freed, Ilan Ganot, Georgia Keresty, Ian Smith.","Advisory vote on executive compensation held every year; PricewaterhouseCoopers ratified as auditor for FY2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-159143","json":"https://secwatch.observer/filing/0001193125-24-159143.json","markdown":"https://secwatch.observer/filing/0001193125-24-159143.md","text":"https://secwatch.observer/filing/0001193125-24-159143.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1707502/000119312524159143/0001193125-24-159143-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1707502/000119312524159143/d845618d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:05:23.086542+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a1a3ed58b3","claim":"Adam Koppel resigned as Director at Solid Biosciences Inc..","evidence_excerpt":"Adam Koppel notified Solid Biosciences Inc. (the “Company”) of his decision to resign as a member of the Company’s Board of Directors (the “Board”), effective as of June 11, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312524159143/0001193125-24-159143-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c159b08908","claim":"Rajeev Shah resigned as Director at Solid Biosciences Inc..","evidence_excerpt":"Rajeev Shah notified the Company of his decision to resign as a member of the Board, effective as of June 11, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1707502/000119312524159143/0001193125-24-159143-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}